Cargando…
Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study
BACKGROUND: COVID-19, an infectious disease caused by SARS-CoV-2, was shown to be associated with an increased risk of new-onset diabetes. Mechanisms contributing to the development of hyperglycemia are still unclear. We aimed to study whether hyperglycemia is related to insulin resistance and/or be...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352285/ https://www.ncbi.nlm.nih.gov/pubmed/37460458 http://dx.doi.org/10.1038/s41387-023-00241-7 |
_version_ | 1785074479150399488 |
---|---|
author | Gojda, Jan Koudelková, Kateřina Ouřadová, Anna Lang, Alexander Krbcová, Magdaléna Gvozdeva, Alexandra Šebo, Viktor Slagmolen, Lotte Potočková, Jana Tůma, Petr Rossmeislová, Lenka Anděl, Michal Karpe, Fredrik Schlesinger, Sabrina |
author_facet | Gojda, Jan Koudelková, Kateřina Ouřadová, Anna Lang, Alexander Krbcová, Magdaléna Gvozdeva, Alexandra Šebo, Viktor Slagmolen, Lotte Potočková, Jana Tůma, Petr Rossmeislová, Lenka Anděl, Michal Karpe, Fredrik Schlesinger, Sabrina |
author_sort | Gojda, Jan |
collection | PubMed |
description | BACKGROUND: COVID-19, an infectious disease caused by SARS-CoV-2, was shown to be associated with an increased risk of new-onset diabetes. Mechanisms contributing to the development of hyperglycemia are still unclear. We aimed to study whether hyperglycemia is related to insulin resistance and/or beta cell dysfunction. MATERIALS AND METHODS: Survivors of severe COVID-19 but without a known history of diabetes were examined at baseline (T0) and after 3 (T3) and 6 (T6) months: corticosteroids use, indirect calorimetry, and OGTT. Insulin response and sensitivity (IS) were expressed as insulinogenic (IGI), disposition (DI), and Matsuda insulin sensitivity index (ISI). Resting energy expenditure (REE) and respiratory quotient (RQ) was calculated from the gas exchange and nitrogen losses. RESULTS: 26 patients (out of 37) with complete outcome data were included in the analysis (age ~59.0 years; BMI ~ 30.4, 35% women). Patients were hypermetabolic at T0 (30.3 ± 4.0 kcal/kg lean mass/day, ~120% predicted) but REE declined over 6 months (ΔT6-T0 mean dif. T6-T0 (95% CI): −5.4 (−6.8, −4.1) kcal/kg FFM/day, p < 0.0001). 17 patients at T0 and 13 patients at T6 had hyperglycemia. None of the patients had positive islet autoantibodies. Insulin sensitivity in T0 was similarly low in hyperglycemic (H) and normoglycemic patients (N) (T0 ISI(H) = 3.12 ± 1.23, ISI(N) = 3.47 ± 1.78, p = 0.44), whereas insulin response was lower in the H group (DI(H) = 3.05 ± 1.79 vs DI(N) = 8.40 ± 5.42, p = 0.003). Over 6 months ISI (ΔT6-T0 mean dif. T6-T0 for ISI (95% CI): 1.84 (0.45, 3.24), p = 0.01)) increased in the H group only. CONCLUSIONS: Patients with severe COVID-19 had increased REE and insulin resistance during the acute phase due to the infection and corticosteroid use, but these effects do not persist during the follow-up period. Only patients with insufficient insulin response developed hyperglycemia, indicating that beta cell dysfunction, rather than insulin resistance, was responsible for its occurrence. |
format | Online Article Text |
id | pubmed-10352285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-103522852023-07-19 Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study Gojda, Jan Koudelková, Kateřina Ouřadová, Anna Lang, Alexander Krbcová, Magdaléna Gvozdeva, Alexandra Šebo, Viktor Slagmolen, Lotte Potočková, Jana Tůma, Petr Rossmeislová, Lenka Anděl, Michal Karpe, Fredrik Schlesinger, Sabrina Nutr Diabetes Article BACKGROUND: COVID-19, an infectious disease caused by SARS-CoV-2, was shown to be associated with an increased risk of new-onset diabetes. Mechanisms contributing to the development of hyperglycemia are still unclear. We aimed to study whether hyperglycemia is related to insulin resistance and/or beta cell dysfunction. MATERIALS AND METHODS: Survivors of severe COVID-19 but without a known history of diabetes were examined at baseline (T0) and after 3 (T3) and 6 (T6) months: corticosteroids use, indirect calorimetry, and OGTT. Insulin response and sensitivity (IS) were expressed as insulinogenic (IGI), disposition (DI), and Matsuda insulin sensitivity index (ISI). Resting energy expenditure (REE) and respiratory quotient (RQ) was calculated from the gas exchange and nitrogen losses. RESULTS: 26 patients (out of 37) with complete outcome data were included in the analysis (age ~59.0 years; BMI ~ 30.4, 35% women). Patients were hypermetabolic at T0 (30.3 ± 4.0 kcal/kg lean mass/day, ~120% predicted) but REE declined over 6 months (ΔT6-T0 mean dif. T6-T0 (95% CI): −5.4 (−6.8, −4.1) kcal/kg FFM/day, p < 0.0001). 17 patients at T0 and 13 patients at T6 had hyperglycemia. None of the patients had positive islet autoantibodies. Insulin sensitivity in T0 was similarly low in hyperglycemic (H) and normoglycemic patients (N) (T0 ISI(H) = 3.12 ± 1.23, ISI(N) = 3.47 ± 1.78, p = 0.44), whereas insulin response was lower in the H group (DI(H) = 3.05 ± 1.79 vs DI(N) = 8.40 ± 5.42, p = 0.003). Over 6 months ISI (ΔT6-T0 mean dif. T6-T0 for ISI (95% CI): 1.84 (0.45, 3.24), p = 0.01)) increased in the H group only. CONCLUSIONS: Patients with severe COVID-19 had increased REE and insulin resistance during the acute phase due to the infection and corticosteroid use, but these effects do not persist during the follow-up period. Only patients with insufficient insulin response developed hyperglycemia, indicating that beta cell dysfunction, rather than insulin resistance, was responsible for its occurrence. Nature Publishing Group UK 2023-07-17 /pmc/articles/PMC10352285/ /pubmed/37460458 http://dx.doi.org/10.1038/s41387-023-00241-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Gojda, Jan Koudelková, Kateřina Ouřadová, Anna Lang, Alexander Krbcová, Magdaléna Gvozdeva, Alexandra Šebo, Viktor Slagmolen, Lotte Potočková, Jana Tůma, Petr Rossmeislová, Lenka Anděl, Michal Karpe, Fredrik Schlesinger, Sabrina Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study |
title | Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study |
title_full | Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study |
title_fullStr | Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study |
title_full_unstemmed | Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study |
title_short | Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study |
title_sort | severe covid-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352285/ https://www.ncbi.nlm.nih.gov/pubmed/37460458 http://dx.doi.org/10.1038/s41387-023-00241-7 |
work_keys_str_mv | AT gojdajan severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT koudelkovakaterina severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT ouradovaanna severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT langalexander severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT krbcovamagdalena severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT gvozdevaalexandra severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT seboviktor severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT slagmolenlotte severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT potockovajana severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT tumapetr severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT rossmeislovalenka severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT andelmichal severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT karpefredrik severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy AT schlesingersabrina severecovid19associatedhyperglycemiaiscausedbybetacelldysfunctionaprospectivecohortstudy |